Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
Predictive Biodosimetry Guidance Planning Working Group Committee, Work group, Advisory group, or Task Force ASPR, FDA NIAID Working group meets monthly with the following goals: 1) Convene a subject matter expert (SME) panel to discuss target product profile (TPP) or device/assay specifications for predictive biodosimetry in early 2021; 2) Identify key SMEs. trans-agency partners and companies; 3) Host meeting, write panel consensus report; 4) Partner with FDA to generate an addendum to the Biodosimetry Guidance; 5) Identify pathways for development and potential pitfalls; 6) Identify funding to support mid-stage to advanced development of predictive biodosimetry devices/assays.
Pregnancy and Birth to 24 Months (P/B-24) Project Committee, Work group, Advisory group, or Task Force CDC, FDA, HRSA, OS NICHD, NCI, NHLBI, NIDDK In 2012, the US Department of Agriculture (USDA) and Department of Health and Human Services (HHS) initiated a project informally called the “B-24 project.” This multi-phase project was originally intended to conclude in 2018 with information that could help the Departments develop dietary recommendations for infants and toddlers for release separate from the Dietary Guidelines. The first phase was completed in 2012-2013. In February 2014, Congress passed the Agricultural Act of 2014, also known as the Farm Bill, mandating that the Dietary Guidelines expand to include dietary guidance for infants and toddlers (from birth to age 24 months), as well as women who are pregnant, beginning with the 2020-2025 edition. Thus, USDA and HHS adjusted the purpose, timeline, and scope of the project. Now called the “Pregnancy and Birth to 24 Months project” or “P/B-24 project” to reflect the addition of pregnant women, this project is a joint initiative led by USDA and HHS in collaboration with programmatic and scientific experts. Rather than concluding in 2018 with dietary recommendations, the goal of the current project is to begin examining topics of public health importance for women who are pregnant and infants and toddlers from birth to 24 months of age. The findings from this work will be made publicly available at the completion of the project.
Pregnancy and Maternal Conditions that Increase Risk of Morbidity and Mortality Virtual Workshop Meeting/ Workshop OASH OD/DPCPSI/ORWH, NICHD, NHLBI, OD/DPCPSI/ODP There were various speakers that presented at this event which took place on May 19-20, 2020.
Pregnant People, Substance Use Disorder and Child Welfare, Sub Interagency Policy Committee (IPC) of the Maternal Health IPC Committee, Work group, Advisory group, or Task Force ACF, ASPE, CDC, HRSA, IHS, SAMHSA, OS, IOS NIDA, NICHD Originating in 2022, the Pregnant People, Substance Use Disorder and Child Welfare Sub Interagency Policy Committee (IPC) of the Maternal Health IPC will address the Biden-Harris Adminstration's First Year Drug Policy Priority, “Explore, identify barriers, and establish policy to help pregnant people with substance use disorder obtain prenatal care and addiction treatment without fear of child removal.” This Sub-IPC will provide short- and long-term federal actions to improve equitable outcomes for families affected by substance use disorder involved in, or at risk of being involved in, the child welfare system. The sub-IPC will prioritize actions that improve equity and are informed by those with lived experience.
PregSource® Management Team Public Education Campaign CDC, HRSA NICHD, NCCIH, NHLBI, NIEHS, NIMHD, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH PregSource is a crowdsourcing research project that aims to learn about the pregnancy experience. Getting information directly from pregnant women about what they feel, think, do, and experience during pregnancy and after giving birth can teach us more about pregnancy and how to improve care.
President's Advisory Council for HIV/AIDS (PACHA) Committee, Work group, Advisory group, or Task Force CDC, CMS, HRSA, IHS, OASH OD/DPCPSI/OAR The Presidential Advisory Council on HIV/AIDS (PACHA) provides advice, information, and recommendations to the Secretary of Health ; Human Services regarding programs, policies, and research to promote effective treatment, prevention and cure of HIV disease and AIDS, including considering common co-morbidities of those infected with HIV as needed to promote effective HIV prevention and treatment and quality services to persons living with HIV disease and AIDS.
President's Emergency Plan for AIDS Relief (PEPFAR) Cervical Cancer Prevention Expert Task Force Committee, Work group, Advisory group, or Task Force CDC NCI, NIAID Experts from CDC, NIH (NCI Division of Cancer Prevention and NIAID) and other US government agencies (DOD, USAID, Department of State, Peace Corps) participate on an expert task force to inform development and oversight of cervical cancer prevention programs within the US President's Emergency Plan for AIDS Relief (PEPFAR) initiative in eight sub-Saharan African countries.
President's Emergency Plan for AIDS Relief (PEPFAR) Implementation Science/Combination Prevention Research Initiative CDC NIAID, FIC, NCI, NIAAA, NIDA, NIMH, OD/DPCPSI/OAR This President’s Emergency Plan for AIDS Relief (PEPFAR) activity focuses on testing treatment as prevention on the population level in South Africa and Zambia. This activity was initiated through the HIV Prevention Trials Network (HPTN), with support of multiple National Institutes of Health (NIH) Institutes and Centers, PEFPAR, and the Bill ; Melinda Gates Foundation. The Requests for Application (RFA) was issued concurrently with a Centers for Disease Control and Prevention (CDC) RFA for combination prevention, and the agencies have worked together to ensure that the studies are complementary and do not overlap.
President's Task Force on Environmental Health Risks and Safety Risks to Children (PTFCEH) Committee, Work group, Advisory group, or Task Force ACF, ASPR, CDC, ATSDR, FDA, OASH, SAMHSA NIEHS, NICHD, NHLBI, NIMH, NIMHD The PTFCEH is the focal point for coordinating federal government efforts to explore, understand, and act together to improve children's environmental health. The Task Force mission includes a goal of prioritizing issues of environmental justice and health disparities among children.
President's Task Force on Environmental Health Risks and Safety Risks to Children: Lead Exposures Subcommittee Committee, Work group, Advisory group, or Task Force ACF, CDC, FDA, HRSA, OS NICHD, NHLBI, NIEHS, OD/DPCPSI/ODP The President's Task Force on Environmental Health and Safety Risks to Children is the focal point for coordinating the federal government's effort to explore, understand, and improve children's environmental health. The task force's objectives are to: 1) develop federal interagency strategies to protect children’s environmental health and safety; 2) identify priority children's environmental health and safety issues best addressed through federal interagency efforts; and 3) communicate information to federal, state, and local decision-makers to protect children from environmental health risks. The Lead Subcommittee seeks to reduce lead exposure and associated harms through collaboration among federal agencies and with a range of stakeholders, including states, tribes and local communities, along with businesses, property owners and parents. This Subcommittee will help federal agencies work strategically and collaboratively to reduce exposure to lead with the aim of ultimately improving children’s health.